AuntMinnie
  • Europe
  • Clinical News
  • Informatics
  • Industry News
  • Practice Management
  • Education
  • Subspecialties
  • More
  • Sign In
  • Board Review
  • CME
  • Careers
  • Cases
  • Conferences
  • Videos
  • Webinars
  • Podcasts
  • Advertising
  • Buyer's Guide
  • Vendors
  • Minnies
Clinical News
  • CT
  • Digital X-Ray
  • Interventional
  • Molecular Imaging
  • MRI
  • Radiation Oncology/Therapy
  • Ultrasound
  • Womens Imaging
Imaging Informatics
  • Advanced Visualization
  • Enterprise Imaging
  • AI
  • Cybersecurity
Industry News
  • Installations
  • Product News
  • Regulatory
  • M&A
  • Market Analysis
Practice Management
  • Administration
  • Associations
  • Careers
  • Equity & Inclusion
  • Legislation
  • Medicolegal
  • Patient Safety
  • Radiologic Technologist
  • Service
  • Salary Scan
Resources
  • Board Review
  • CME
  • Careers
  • Cases
  • Conferences
  • Videos
  • Webinars
  • Podcasts
  • Advertising
  • Buyer's Guide
  • Vendors
  • Minnies
User Tools
  • Sign In
More
  • About Us
  • Advertising
  • Help
Follow AuntMinnie
Facebook iconTwitter X icon LinkedIn iconInstagram icon
  • Europe
  • Clinical News
    • CT
    • Digital X-Ray
    • Interventional
    • Molecular Imaging
    • MRI
    • Radiation Oncology/Therapy
    • Ultrasound
    • Womens Imaging
  • Informatics
    • Advanced Visualization
    • Enterprise Imaging
    • AI
    • Cybersecurity
  • Industry News
    • Installations
    • Product News
    • Regulatory
    • M&A
    • Market Analysis
  • Practice Management
    • Administration
    • Associations
    • Careers
    • Equity & Inclusion
    • Legislation
    • Medicolegal
    • Patient Safety
    • Radiologic Technologist
    • Service
    • Salary Scan
  • Education
    • Medical Students
    • Residents/Fellows
  • Subspecialties
    • Breast Imaging
    • CV
    • Chest
    • Emergency
    • GI
    • GU
    • Head & Neck
    • Interventional
    • Physics
    • MSK
    • Neuro
    • Nuclear
    • Pediatric
    • Radiation Oncology
  • More
  • Board Review
  • CME
  • Careers
  • Cases
  • Conferences
  • Videos
  • Webinars
  • Podcasts
  • Advertising
  • Buyer's Guide
  • Vendors
  • Minnies
  • Sign In
Follow AuntMinnie
Facebook iconTwitter X icon LinkedIn iconInstagram icon

Top Story

Doctor Patient Consult Tablet
Womens Imaging
Study highlights risk-based breast cancer screening; ACR responds
A study showing the potential benefits of risk-based breast cancer screening has drawn criticism from the ACR.
Featured
At RSNA 2025, thoracic radiologists debated using autonomous AI for chest radiograph interpretation. They also fielded many audience questions and comments as well.
AI
Is AI ready for autonomous reads of chest x-rays?
Ai Face
AI
Patients support AI in radiology, but not as a standalone reader
Latest News
Lung Cancer
Lung cancer rates low on chest CT after incidental neck imaging findings
December 11, 2025
Football Players Scrimmage
Adding AI to MRI improves return to play classification frameworks
December 10, 2025
Runner Street Thumbnail Adobe Augustas Cetkauskas
Marathon training does not have long-term negative effects on heart
December 10, 2025
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Phase I trial reveals the potential of a new PSMA-PET tracer
December 9, 2025
Cases of the Week
Check out our Cases of the Week!
59-year-old woman with new daily persistent headache
A 59-year-old woman was initially evaluated and referred by a fellowship-trained headache neurologist with a history of severe refractory daily headaches.
41-year-old woman with breast mass
60-year-old woman with right arm weakness
View All Cases
Clinical News
Doctor Patient Consult Tablet
Womens Imaging
Study highlights risk-based breast cancer screening; ACR responds
CT
Lung cancer rates low on chest CT after incidental neck imaging findings
MRI
Adding AI to MRI improves return to play classification frameworks
Ultrasound
Marathon training does not have long-term negative effects on heart
Molecular Imaging
Phase I trial reveals the potential of a new PSMA-PET tracer
View More »
AI
At RSNA 2025, thoracic radiologists debated using autonomous AI for chest radiograph interpretation. They also fielded many audience questions and comments as well.
AI
Is AI ready for autonomous reads of chest x-rays?
AI
Patients support AI in radiology, but not as a standalone reader
Ultrasound
AI ultrasound tool could reduce unnecessary biopsies by 60%
AI
Your network doesn't matter anymore
AI
The paradox of AI in lung nodules
View More »
Industry News
Computer Data
PACS/VNA
Paratus consolidates imaging business in Rochester, NY
Associations
AdvaMed names new board of directors chair
Practice Management
HAP adds Summit Radiology to clientele
CT
Canon showcases CT innovations at RSNA 2025
Radiation Oncology/Therapy
Telix and Varian enter research collaboration
View More »
Podcasts
Latest Episode
Podcast: Sherpa doctor recalls career journey starting at Mt. Everest
More episodes »
Practice Management
Computer Data
Paratus consolidates imaging business in Rochester, NY
Parent company Paratus, which acquired aycan in 2023, announced the move and iQ IMAGE's relocation from Charlotte, NC.
Is AI ready for autonomous reads of chest x-rays?
AdvaMed names new board of directors chair
More Practice Management
More from AuntMinnie
Paratus consolidates imaging business in Rochester, NY
By AuntMinnie.com staff writers
Parent company Paratus, which acquired aycan in 2023, announced the move and iQ IMAGE's relocation from Charlotte, NC.
December 12, 2025
Computer Data
AdvaMed names new board of directors chair
By AuntMinnie.com staff writers
AdvaMed has named Resmed Chairman and CEO Michael Farrell as its next board of directors chair.
December 11, 2025
Business Network Concept 400
HAP adds Summit Radiology to clientele
By AuntMinnie.com staff writers
Healthcare Administrative Partners (HAP) has added its first Indiana-based client, Summit Radiology in Fort Wayne, to its roster.
December 11, 2025
Radiologist Brain Scans Monitor 400
Canon showcases CT innovations at RSNA 2025
By AuntMinnie.com staff writers
Canon exhibited two work-in-progress technologies in a research-focused section of its booth.
December 10, 2025
Canon
Telix and Varian enter research collaboration
By AuntMinnie.com staff writers
The two firms will identify opportunities to use Telix’s prostate cancer PET imaging agents in selecting patients for radiation therapy.
December 10, 2025
Acquisitions
Imaging Biometrics and GE HealthCare expand agreement
By AuntMinnie.com staff writers
GE HealthCare will now distribute Imaging Biometrics’ Fractional Tumor Burden (FTB) Express and QSMetric software applications.
December 10, 2025
Ai Handshake
Raidium unveils AI-native PACS viewer at RSNA 2025
By AuntMinnie.com staff writers
French precision radiology developer Raidium unveiled its work-in-progress AI-native PACS viewer at RSNA 2025.
December 10, 2025
Artificial Intelligence Ai Binary Code
Radiologists can designate nonmass lesions on breast ultrasound
By Amerigo Allegretto
Breast radiologists achieved moderate to substantial interreader agreement for classifying nonmass lesions on ultrasound.
December 9, 2025
Images depict a 50-year-old woman with a lesion detected during screening ultrasound. (A) Transverse and (B) longitudinal images reveal a 0.5-cm hypoechoic lesion (arrow) in the left breast. (C) Transverse color Doppler ultrasound image does not show an increase in vascularity. Two readers classified the lesion as a mass, whereas two others categorized it as a nonmass lesion, leading to its designation as a controversial nonmass lesion. Ultrasound-guided core needle biopsy and subsequent pathologic examination confirmed a nonproliferative breast change.
Long COVID's neurological effects persist
By Kate Madden Yee
Long COVID is typically defined as persistent symptoms beyond four weeks from onset of the illness.
December 9, 2025
Coronavirus
A2z raises $4.5M in seed round for CT triage system
By AuntMinnie.com staff writers
A2z Radiology has raised $4.5 million in a seed round for R&D and the commercial deployment of its abdominal/pelvic CT triage algorithm.
December 9, 2025
Computer Brain Money 400
MRI proves effective for tracking results of obesity interventions
By Kate Madden Yee
MRI is a powerful tool to monitor skeletal muscle adaptations during lifestyle interventions for obesity, researchers noted.
December 8, 2025
Obesity Text2
TVR-PET/CT shows promise in primary hyperparathyroidism
By Will Morton
Gallium-68 trivehexin PET/CT was superior for identifying lesions over technetium-99m sestamibi SPECT.
December 8, 2025
Phpt
AuntMinnie
Topics
  • Clinical News
  • Imaging Informatics
  • Industry News
  • Practice Management
  • Radiology Education
  • Subspecialties
Resources
  • Board Review
  • CME
  • Careers
  • Cases
  • Conferences
  • Videos
  • Webinars
  • Podcasts
  • Advertising
  • Buyer's Guide
  • Vendors
  • Minnies
More
  • About Us
  • Advertising
  • Help
Follow AuntMinnie
Facebook iconTwitter X icon LinkedIn iconInstagram icon
  1. Privacy Policy
  2. Privacy Settings
  3. Terms & Conditions
  4. Contact Us
  5. Site Map
  6. Home
© 2025 Science and Medicine Group. All rights reserved.